EPG Online Twitter 
EPG Online Blog 
Disease Knowledge Drug Updates
- Enbrel 25 mg powder and solvent for solution for injection
- Sustiva 50 mg, 100 mg and 200 mg Hard Capsules
- Sandostatin LAR
- Difflam Oral Rinse
- Teoptic 1% - Teoptic 2%
- Erythroped A 500 mg Tablets
- Enalapril 5mg Tablets
- Viskaldix Tablets
- Aricept Tablets
- Difflam Cream
- Alfentanil 500 micrograms/ml solution for injection
- Revlimid
- Benadryl Plus Capsules
- Diclomax Retard
- Voltarol Tablets
- Virgan
- DIXARIT (menopausal disorders)
- Rapiscan (regadenoson)
- Neurontin Capsules and Tablets
- Aprovel Film-Coated Tablets (sanofi-aventis Bristol-Myers Squibb SNC)
- Foradil
- Nystatin-Dome Suspension 100,000 I.U./ml
- Meningitec in pre-filled syringe
- Catapres Tablets 100mcg
- Kemadrin 5 mg Tablets
- SECTRAL 400mg tablets
- Sectral 100mg and 200mg
- Eucardic 25mg Tablets
- ALDOMET Tablets 250 mg
- Parvolex 200 mg/ml Concentrate for Solution for Infusion
- Mifegyne
- Pedea 5 mg/ml solution for injection
- Eucardic 12.5mg Tablets
- Qvar 100 Easi-Breathe
- Qvar 50 Easi-Breathe
- Eucardic 6.25mg Tablets
- Qvar MDI 50 micrograms
- Sonata 5 mg hard capsules
- PRO-EPANUTIN
- Xarelto 20mg film-coated tablets
Migraine
Please note- The EPG Migraine Knowledge Centre is for Doctors and other Healthcare Professionals. Enter the Migraine Knowledge Centre.
Migraine is a severe, episodic disorder with freedom from symptoms between attacks. Attacks are characterised by transient focal neurological symptoms, headache, or both.
Correctly diagnosing a migraine headache enables prompt and appropriate therapeutic intervention, reducing the distress and pain experienced by patients. An incorrect diagnosis of migraine can have a significant effect on both migraineurs and their families.
Several sets of guidelines have been developed to assist in the diagnosis of migraine.
Among migraineurs, understanding and assessing the severity and disability of a patient’s illness is an important step in ascertaining their treatment needs.
The Migraine Disability Assessment (MIDAS) questionnaire is a self-administered form that assesses the impact that migraine has on a patient’s work and social life. It can be used prior to and at the time of an initial consultation and throughout treatment to monitor the patient’s progress.
The use of a headache diary, which allows patients to record events that play a role in their headaches, is also a useful tool that may aid the physician in the diagnosis of migraine.
Despite the availability of migraine-specific medications such as the triptans, which are effective and well tolerated for the acute treatment of migraine, many migraineurs lapse from physician care before being prescribed an effective treatment.
It is advised that users of this resource consult their local treatment guidelines before initiating any treatment programme for a patient with migraine. Once migraine is diagnosed, patients and physicians should decide together how best to treat acute attacks and whether to use preventive medications.
Enter the Migraine Knowledge Centre
What’s in the Migraine Knowledge Centre?
- Home
- Is it Migraine?
- Migraine: Quick Check
- Migraine without aura: International Headache Society classification
- Migraine with typical aura: International Headache Society classification
- Headache
- Primary headache
- Secondary headache
- Migraine Aetiology
- What is Migraine?
- What Causes Migraine?
- Migraine triggers
- Migraine Epidemiology
- Economic Impact of Migraine
- Treating Migraine
- Screening
- Diagnosis
- Migraine Treatment Guidelines
- Headache Care for Practising Physicians (HCPC)
- US Headache Consortium Guidelines
- Migraine Treatment Options
- Acute Migraine Treatments
- Triptans
- Other acute migraine treatments
- Preventative Migraine Treatments
- Non-Pharmacological Migraine Treatments
- Migraine Treatment Strategies
- Step Care Across Attacks
- Step Care Within Attacks
- Stratified Care
- Zomig
- Zomig Nasal Spray
- 'Zomig Rapimelt'
- 'Zomig' Classic Tablets
- Zomig full prescribing information
- Migraine Disability Assessment (MIDAS) Questionnaire
- Patient Diary
- Managing Your Migraine Booklet
- Migraine & Headache Resources
- American Headache Society (AHS)
- Analgesics
- Migraine Aura
- Basilar-type migraine
- Biofeedback
- Chronic migraine
- Chronic paroxysmal hemicrania
- Classic migraine (migraine with typical aura)
- Cluster headache
- Cognitive behavioural therapy
- Common migraine (migraine without aura)
- Disability In Strategies of Care (DISC) study
- Ergotamine
- Familial hemiplegic migraine
- Headache Care for Practising Physicians (HCPC)
- Headache diary
- International Headache Society (IHS)
- Landmark study
- Medication-overuse headache
- Menstrual migraine
- Migraine Disability Assessment (MIDAS) questionnaire
- Migraineur
- New daily persistent headache (NDPH)
- ODT
- Osmophobia
- Phonophobia
- Photophobia
- Primary headache
- Prophylactic medication
- Secondary headache
- Serotonin
- Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT)
- Sinister headache
- Tension-type headache
- Transcutaneous electrical nerve stimulation (TENS)
- Trigger
- Triptans
- US Headache Consortium
- SANOMIGRAN
Prophylactic treatment of recurrent vascular headaches, including classical migraine , common migraine and cluster headaches (periodic migrainous neuralgia). It is not effective in relieving migraine attacks once in progress ... - TOPAMAX
... Migraine Topamax is indicated in adults for the prophylaxis of migraine headache. Initiation of treatment with topiramate should be restricted to specialist care and treatment should be managed under specialist supervision or shared care arrangements. Prophylactic treatment of migraine may be ... - MAXOLON 10mg Tablets
... Post-anaesthetic vomiting Migraine: 'Maxolon' relieves symptoms of nausea and vomiting, and overcomes gastric stasis associated with attacks of migraine. This improvement in gastric emptying assists the absorption of concurrently administered oral anti-migraine therapy (e.g. paracetamol) which may ... - IMIGRAN RECOVERY
Subcutaneous Injection is indicated for the acute relief of migraine attacks, with or without aura, and for the acute treatment of cluster headache. Imigran should only be used where there is a clear diagnosis of migraine or cluster headache ... - MIGRALEVE
Migraleve Ultra are indicated for the acute relief of migraine attacks, with or without aura. Migraleve Ultra should only be used where there is a clear diagnosis of migraine ... - IMIGRAN Radis tablets (50mg and 100mg)
Imigran tablets are indicated for the acute relief of migraine attacks, with or without aura. Imigran should only be used where there is a clear diagnosis of migraine ...